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Abstract
Background—Impaired growth and de-
velopment of the respiratory system dur-
ing fetal and early postnatal life may have
important implications for lung develop-
ment and later lung health. The aim of this
study was to examine the association of
diminished premorbid airway function,
prior wheezing, and maternal smoking
with airway function at 1 year of age.
Methods—Respiratory function was
measured at the end of the first year in 100
of 108 healthy term infants (93%) in whom
similar measurements had been under-
taken prior to any respiratory illness at 8
weeks. Physician diagnosed wheezing epi-
sodes were identified retrospectively from
medical records.
Results—At 1 year specific airway con-
ductance during end expiration (sGawEE;
/s/kPa) was significantly diminished in
those infants with prior wheezing (95% CI
wheeze/no wheeze –0.76 to –0.14), mothers
who smoked (95% CI smoke/no smoke
–0.81 to –0.27), a family history of asthma
(95% CI family history/no family history
–0.62 to 0.00), or diminished premorbid
sGawEE (95% CI –0.13 to –0.43/s/kPa per
unit reduction sGawEE at 8 weeks). In a
multivariate model only maternal smok-
ing and diminished premorbid sGawEE
were independently associated with di-
minished sGawEE at 1 year.
Conclusions—Diminished airway func-
tion at the end of the first year appears to
be mediated by impaired airway develop-
ment during early life as well as by
exposure to maternal smoking. These
findings are consistent with the hypothesis
that, at a population level, diminished
premorbid airway function provides the
link between wheezing lower respiratory
illness and diminished airway function at
1 year. Maternal smoking remains an
important and avoidable cause of im-
paired airway development and function
in infancy.
(Thorax 2001;56:680–686)
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Diminished respiratory function in the first few
months of life precedes and is predictive of
wheezing in early childhood,1–3 an association
which may be mediated by genetic and
environmental factors.4 It has been suggested
that suboptimal development of the respiratory
system during fetal life or early childhood may
influence airway function adversely throughout
life.5 6 Diminished airway function has been
reported in young children with prior early
wheezing illness.7 8 However, the interplay
between premorbid respiratory function, prior
wheezing lower respiratory illness, and envi-
ronmental and genetic influences and their
respective contributions to respiratory function
in later infancy remains unclear, reflecting a
lack of population based studies with sequen-
tial measurements of infant lung function.
Although the respiratory system grows and
develops most rapidly during fetal and early
postnatal life,9 there are few longitudinal lung
function data available for the early years. Post-
natal lung growth may be diminished among
those exposed to wheezing illnesses or adverse
environmental factors during the first year, and
this may be more marked among those with
prior impairment of respiratory function.
Alternatively, the level of respiratory function
in later infancy may be independent of prior
wheezing or of preceding level of respiratory
function.
The aim of this prospective community
based study was to examine the association
between respiratory function at 1 year of age,
prior wheezing, and premorbid respiratory
function. It was hypothesised that airway func-
tion at 1 year would be diminished in infants
with prior wheezing, but that this association
would be mediated by diminished premorbid
airway function measured shortly after birth,
before the development of upper or lower
respiratory symptoms.
Methods
STUDY POPULATION
Eligible infants were identified from consecu-
tive births to women registered with two health
centres in inner London. Healthy white term
infants (>35 weeks) without major congenital
abnormalities or neonatal or prior respiratory
illness were eligible. Families were not ap-
proached if social or medical reasons precluded
contact, and those planning to leave the area
over the next year were ineligible. Parents were
contacted by letter and written informed
parental consent obtained following at least
one prearranged home visit by the research
nurse. This study was approved by the ethics
committee of the Hospitals for Sick Children,
London.
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RESPIRATORY FUNCTION
Respiratory function was measured on two
occasions in each infant: before the develop-
ment of any respiratory symptoms when aged
1–3 months, and at approximately 1 year of age
when infants were symptom free and when at
least 2 weeks had elapsed since any upper and
lower respiratory symptoms. Measurements
were made following sedation with triclofos
sodium elixir (75–100 mg/kg) during behav-
iourally determined quiet sleep as described
previously.10–12 On each test occasion body
weight was measured to the nearest 100 g and
crown-heel length to the nearest 0.1 cm.10
Airway function was assessed from plethys-
mographic measurements of airway resistance
(Raw) from which conductance (Gaw), the
reciprocal of Raw, was calculated.11 Since there
is rapid growth of the airways during the first
year of life, resistance will be higher (and con-
ductance lower) in smaller, younger infants. By
dividing conductance by functional residual
capacity (FRCpleth) to obtain specific con-
ductance (sGaw), account can be taken of
these growth related changes.
Measurements of sGaw made during end
expiration (sGawEE) were chosen as the princi-
pal measure of airway function in this study.
These provide a measure of eVective airway
calibre corrected for lung size and will be
reduced if airway calibre is diminished and/or
lung volume increased in relation to body size.
Similar measurements made during initial
inspiration (sGawII) are reported but were not
used as outcomes in regression analyses.
Respiratory function parameters were calcu-
lated according to previously established crite-
ria.11 12 Respiratory system compliance was
measured using the multiple occlusion tech-
nique10 to allow diVerences in airway function
to be interpreted with respect to any underlying
diVerences in elastic recoil. Specific compli-
ance (sCrs, compliance/FRCpleth) was also
calculated to determine whether changes in
elastic recoil during the first year reflected
increases in FRCpleth.
Although of uncertain relevance as measures
of airway function,13 tidal breathing parameters
including respiratory rate (RR) and the time to
peak tidal expiratory flow as a proportion of
total expiratory time (tPTEF:tE) were also calcu-
lated. This allowed comparison with previously
published work in which tPTEF:tE has been
reported to be diminished in young infants who
subsequently wheeze in early childhood1 and in
those with a family history of asthma and
parental smoking.14–16
WHEEZING AND OTHER FACTORS
Obstetric, medical, social, and demographic
details were obtained at recruitment when
mothers were asked to report their smoking
during pregnancy and whether any first degree
relative of the child had ever been diagnosed
with asthma. Gestation-specific birth weight
standard deviation scores were calculated for
each infant.17 Maternal smoking postnatally as
well as exposure to tobacco smoke from other
household members was assessed from the
parental report at the second test when a speci-
men of urine was collected from each infant
and frozen at –20°C within two hours of void-
ing. Urinary cotinine levels were assayed by gas
liquid chromatography18 and expressed as ng
cotinine/mg creatinine. Following the second
respiratory function test, physician diagnosed
episodes of wheezing in the first year of life
were identified retrospectively from the child’s
practice medical record by a researcher blinded
to the results of the respiratory function tests.
STATISTICAL METHODS
sGawEE and tPTEF:tE at 1 year were compared
by sex, prior wheezing status, family history of
asthma, postnatal exposure to maternal smok-
ing, and sGawEE at 8 weeks (SPSS for
Windows version 7.5.1). The association be-
tween sGawEE at 1 year and sex, prior
wheezing, maternal smoking, family history of
asthma, or sGawEE measured shortly after birth
was examined using linear regression. Similar
analyses were carried out for tPTEF:tE at 1 year.
This study was established to examine the
association of five potential independent vari-
ables with airway function. Sample size calcu-
lations suggested that, should these variables
together account for 16% or more of the
variability in sGawEE at 1 year, a sample of 85
infants would allow this to be detected with
80% power at the 5% significance level, or with
90% power if they accounted for 21% or more
of the variability.19 Should any single variable
account for more than 9% of the variability in
sGawEE at 1 year, this sample would allow this
to be detected with 80% power, or with 90%
power for more than 14% of the variability.
Results
Over a 5 year period the parents of 118 of 300
eligible infants (39%) born in the study
practices and successfully contacted consented
to their child having respiratory function tests.
Following recruitment, 10 of these children
developed respiratory symptoms before respi-
ratory tests could be arranged and were hence
excluded from respiratory function testing.
Parents of a further 148 infants declined testing
but agreed to participate in a parallel morbidity
study so that background data were available
for 266 (89%) of all eligible and contacted
infants. As reported previously,2 infants whose
parents agreed to respiratory function tests
were similar with respect to birth weight,
gestational age, sex distribution, maternal age
and educational level, and prevalence of family
history of asthma to those for whom only back-
ground data were available.
Respiratory function was measured on the
first test occasion and before development of
any upper or lower respiratory symptoms in
108 children. During their first year, five of
these 108 infants were lost to follow up, while
the parents of a further three declined the 1
year test. Thus, respiratory function was
measured on a second occasion in 100 children
(93% of those enrolled; 51 boys) who form the
basis of this report. Paired measurements of
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tPTEF:tE at 8 weeks and 1 year of age were suc-
cessfully obtained in all 100 infants. Measure-
ments of sGawEE were successful at 1 year in 98
infants, including 85 (99%) of the 86 with
similar measurements at 8 weeks of age.2
Details of respiratory function on each test
occasion for all infants and within-subject
changes between occasions for infants with
complete data on both occasions are summa-
rised in table 1.
The second test was performed at a mean
(range) age of 56 weeks (48–78), an average 48
weeks after the first test (95% CI 47 to 49
weeks). During this interval body weight
increased on average by 5.0 kg and crown–heel
length by 20.0 cm, while FRCpleth doubled
and sGawEE, sGawII, and tPTEF:tE declined to a
small but significant extent (table 1). Respira-
tory rate declined from 46 to 30 bpm whereas
sCrs remained constant, reflecting the parallel
increase in lung volume and compliance during
the first year of life.
During the interval between the first and
second respiratory function test, 27 of 98 chil-
dren (28%) whose primary medical care record
was successfully located experienced at least
one episode of physician diagnosed wheezing.
Of those with wheezing, 11 had more than one
episode (two episodes in five children, three
episodes in two, four episodes in three, and five
episodes in one). Four of the 27 children
required at least one hospital admission for
management of their wheezing episode and a
further two were seen in hospital during an
acute episode, but not admitted, while 21 were
managed by their general practitioner. Nine of
the 27 were diagnosed clinically with acute
bronchiolitis and 18 were treated on at least
one occasion with either oral or nebulised sal-
butamol.
Infants with prior wheezing were more likely
to have mothers who smoked, to have a family
history of asthma, to weigh significantly less at
birth, to be born at a slightly earlier gestation,
and to be of lower birth weight for gestational
age than those without such symptoms (table
2). While there was a slight excess of boys
among those with wheezing, this diVerence was
not statistically significant (p=0.06).
Respiratory function at 1 year of age was
compared in those with and without prior
wheezing, including 83 infants with complete
data on wheezing and sGawEE for both test
occasions, and 97 infants with complete data
on wheezing and tPTEF:tE on both test occa-
sions (table 3). At the time of the second respi-
ratory function test, infants with prior wheez-
ing were on average 2 weeks older but of similar
body weight and crown–heel length to those
with no wheezing. This reflected the fact that
respiratory function tests sometimes had to be
postponed until infants were free of respiratory
tract symptoms. Among those with prior
wheezing, RawEE at 1 year was significantly
higher than in those without prior wheezing,
but values of FRCpleth were similar. sGawEE
was thus significantly lower among those with
prior wheezing. A similar pattern was observed
for RawII and sGawII. Although mean tPTEF:tE
tended to be lower among those with prior
wheezing, this was not statistically significant
(table 3; p=0.314). sCrs and respiratory rate
were also similar between the two groups.
FRCpleth and Crs were significantly higher
in boys, reflecting their heavier body weight at
testing (95% CI of diVerence between boys and
girls: 0.3 to 1.1 kg; p=0.002). Thus, weight
adjusted values for FRCpleth and Crs were not
statistically diVerent (data not shown). Boys
and girls did not otherwise diVer in respiratory
function (95% CI of diVerence between boys
and girls: sGawEE –0.23 to 0.34 /s/kPa; tPTEF:tE
–0.045 to 0.17).
A positive family history of asthma was
reported in 28 children, and in 17 the mother
Table 1 Infant characteristics by test occasion
First test* Second test*
Mean (95% CI)† within-subject diVerence
between second and first test
Postnatal age (weeks) 7.8 (1.4) 55.9 (4.9) 48.2 (47.2 to 49.2)
Body weight (kg) 4.9 (0.7) 9.9 (1.2) 5.0 (4.8 to 5.2)
Crown–heel length (cm) 57.6 (2.5) 77.6 (2.7) 20.0 (19.5 to 20.5)
FRCpleth (ml) 112 (26) 249 (42) 136 (129 to 144)‡
RawII (kPa/l.s) 4.11 (2.02) 2.33 (1.30) –1.85 (–2.30 to –1.39)§
RawEE (kPa/l.s) 4.57 (2.46) 2.46 (1.35) –2.24 (–2.73 to –1.76)§
sGawII (/s/kPa) 2.64 (1.02) 2.09 (0.71) –0.51 (–0.76 to –0.27)§
sGawEE (/s/kPa) 2.41 (0.93) 1.99 (0.71) –0.36 (–0.57 to –0.16)§
Crs (ml/kPa) 65.6 (10.7) 145.5 (20.9) 80.4 (76.9 to 83.9)¶
sCrs (/kPa) 0.61 (0.12) 0.60 (0.10) –0.01 (–0.04 to 0.02)**
tPTEF:tE 0.324 (0.074) 0.299 (0.079) –0.024 (–0.040 to –0.008)
Respiratory rate (bpm) 46 (9) 30 (4) –16 (–17 to –14)
FRCpleth = functional residual capacity determined plethysmographically; Raw = airway resistance measured at initial inspiration
(RawII) or end expiration (RawEE); sGaw = specific conductance measured at initial inspiration (sGawII) or end expiration (sGawEE);
sCrs = specific respiratory compliance; tPTEF:tE = time to peak tidal expiratory flow as a proportion of total expiratory time.
*Data summarised as mean (SD).
†95% CI = 95% confidence interval of diVerence in means for 100 infants unless otherwise stated.
‡n=99; §n=86; ¶n=92; **n=91.
Table 2 Background characteristics at 1 year by prior wheezing statusa
Wheeze
(n=27)
No wheeze
(n=71)
95% CI of diVerence
between wheeze and
no wheezeb
Boys (n) 63% (17) 45% (32) –4 to 40
First degree relative with asthma (n) 52% (14) 18% (13) 13 to 53§
Postnatal maternal smoking (n) 63% (17) 30% (21) 11 to 55†
Birth weight (g) 3189 (557) 3508 (456) –536 to –101†
Gestation (weeks) 39.4 (1.7) 40.2 (1.4) –1.4 to –0.1*
Gestation-specific birthweight SD score17 –0.44 (0.87) 0.00 (1.00) –0.87 to 0.00*
Birth weight centile17 35.5 (25.1) 49.4 (28.4) –26.3 to –1.6*
Urinary cotinine:creatinine (ng:mg)c 120.3
(56.5–306.3)
46.0
(16.2–107.3)
1.5 to 4.5§
aData shown as mean (SD) for continuous and % (n) for categorical variables; information on
prior wheeze missing in two infants.
bConfidence intervals of diVerence in group means or percentages.
cUrinary cotinine:creatinine ratios shown as geometric means (interquartile ranges) and their ratio
(95% CI) with:without prior wheezing.
*p<0.05; †p<0.01; §p<0.001 (two sided t test for independent samples).
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was the aVected family member. sGawEE was
significantly lower in those with a positive fam-
ily history than in those without (mean (SD):
1.77 (0.63)/s/kPa v 2.09 (0.72)/s/kPa; 95% CI
of diVerence –0.62 to –0.003; p<0.05) which,
in turn, reflects increased expiratory airway
resistance among those with a family history
(95% CI of diVerence 0.00 to 1.19 kPa/l.s;
p=0.05). Infants with wheezing were more
likely to have a first degree relative with asthma
(table 2).
Four of the 41 mothers who reported smok-
ing during pregnancy ceased smoking once
their child was born, while one mother who
had not smoked when pregnant started smok-
ing postnatally. Thus, the mothers of 38
children reported smoking since their child was
born. Geometric mean urinary cotinine levels
were 157.8 ng/mg creatinine in the infants
whose mothers smoked postnatally and
30.0 ng/mg creatinine in those whose mothers
did not smoke (95% CI of ratio smoke expos-
ed:not smoke exposed 3.6 to 7.7; p<0.001).
Infants who developed wheezing were twice as
likely to have mothers who smoked postnatally
(table 2). Infants of smoking mothers were of
similar gestation but significantly lighter at
birth (95% CI of diVerence –580 to –200 g;
p<0.001), resulting in significantly lower birth
weight standard deviation scores (95% CI of
diVerence –0.96 to –0.19; p<0.01). However,
at the time of the second lung function tests
there were no significant diVerences in post-
natal age, body weight, or crown–heel length
(table 4). Both RawII and RawEE were signifi-
cantly raised and sGawII and sGawEE were sig-
nificantly diminished in those infants whose
mothers smoked postnatally, although FRC-
pleth, tPTEF:tE, and sCrs were similar.
sGawEE at 8 weeks of age and 1 year were
significantly correlated (fig 1; Spearman’s two
tailed correlation coeYcient 0.374; p<0.01), as
were tPTEF:tE at 8 weeks and 1 year (Spear-
man’s two tailed correlation coeYcient 0.423;
p<0.01). The association between sGawEE at 8
weeks of age and at 1 year is shown according
to prior wheezing status in fig 1, and according
to maternal smoking status in fig 2. In univari-
ate analyses, sGawEE at 1 year was significantly
and negatively associated with prior wheezing,
being diminished on average by 0.45/s/kPa in
those with prior wheezing (95% CI –0.76 to
–0.14; p=0.005; table 5). It was also signifi-
cantly and negatively associated with a family
history of asthma and maternal smoking post-
natally. sGawEE was significantly lower at 1 year
in those with diminished sGawEE at 8 weeks of
age.
In a multivariate analysis prior wheeze and a
family history of asthma were no longer signifi-
cantly associated with sGawEE at 1 year (table
5). However, at 1 year sGawEE remained
significantly diminished in those whose moth-
ers reported smoking postnatally (95% CI
–0.71 to –0.10; p=0.01) and in those with
Table 3 Respiratory function at 1 year by prior wheezing status
Wheeze (n=27)
No wheeze
(n=71)
95% CI of diVerence
between wheeze and no
wheeze
Age (weeks) 57.5 (5.8) 55.2 (4.3) 0.1 to 4.4*
Body weight (kg) 9.9 (1.3) 9.9 (1.1) –0.5 to 0.5
Crown–heel length (cm) 77.3 (3.1) 77.7 (2.5) –1.6 to 0.8
FRCpleth (ml) 246 (43) 249 (43) –22 to 16
RawII (kPa/l.s) 2.75 (1.34) 2.18 (1.27) –0.03 to 1.15
RawEE (kPa/l.s) 2.92 (1.43) 2.30 (1.30) 0.01 to 1.23*
sGawII (/s/kPa) 1.80 (0.66) 2.19 (0.69) –0.70 to –0.08*
sGawEE (/s/kPa) 1.66 (0.53) 2.11 (0.73) –0.76 to –0.14†
sCrs (/kPa) 0.59 (0.07) 0.60 (0.11) –0.06 to 0.03
tPTEF:tE 0.287 (0.058) 0.305 (0.086) –0.054 to 0.017
Respiratory rate (bpm) 30 (4) 30 (4) –2 to 2
Abbreviations as in footnote to table 1.
*p<0.05; †p<0.01(two sided t test for independent samples).
Table 4 Respiratory function at 1 year by maternal smoking postnatally
Mother smoker
(n=38)
Mother non-smoker
(n=62)
95% CI of diVerence
between smoker and
non-smoker
Age (weeks) 56.0 (5.6) 55.9 (4.4) –1.9 to 2.1
Body weight (kg) 9.8 (1.3) 10.0 (1.1) –0.6 to 0.3
Crown–heel length (cm) 77.2 (2.6) 77.9 (2.7) –1.8 to 0.4
Urinary cotinine:creatinine
(ng:mg)a
157.8
(92.3–300.5)
30.0
(13.5–55.4)
3.6 to 7.7§
FRCpleth (ml) 243 (44) 251 (41) –26 to 9
RawII (kPa/l.s) 2.76 (1.42) 2.06 (1.14) 0.16 to 0.25*
RawEE (kPa/l.s) 3.03 (1.62) 2.10 (1.00) 0.40 to 1.45†
sGawII (/s/kPa) 1.81 (0.63) 2.27 (0.70) –0.73 to –0.18†
sGawEE (/s/kPa) 1.66 (0.60) 2.20 (0.69) –0.81 to –0.27§
sCrs (kPa) 0.58 (0.09) 0.61 (0.10) –0.07 to 0.01
tPTEF:tE 0.297 (0.084) 0.300 (0.076) –0.036 to 0.029
Respiratory rate (bpm) 29 (3) 30 (4) –2 to 1
Abbreviations as for footnote to table 1. aUrinary cotinine:creatinine ratios shown as geometric
means (interquartile ranges) and their ratio (95% CI) with:without exposure to maternal smok-
ing. Other values are mean (SD). *p<0.05; †p<0.01; §p<0.001 (two sided t test for independent
samples).
Figure 1 End expiratory specific airway conductance
(/s/kPa) measured at 8 weeks and 1 year according to prior
wheezing status. Solid triangles = infants with prior
wheeze; open triangles = infants without prior wheeze.
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Figure 2 End expiratory specific airway conductance
(/s/kPa) measured at 8 weeks and 1 year according to prior
exposure to maternal smoking. Solid triangles = infants
whose mother smoked; open triangles = infants whose
mother did not smoke.
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diminished sGawEE at 8 weeks (95% CI –0.36
to –0.03; p=0.018). A model incorporating
only maternal smoking and sGawEE at 8 weeks
accounted for 23% of the variation in sGawEE
at 1 year (r2=0.228).
Discussion
The longitudinal data obtained over the first
year of life in this cohort confirm that this is a
period of considerable growth and develop-
ment of the respiratory system with a twofold
increase in FRCpleth, a halving of Raw, and a
small reduction in sGaw but no change in sCrs.
Respiratory rate and tPTEF:tE also declined sig-
nificantly with increasing age, which may
reflect continued alveolar and airway develop-
ment as well as greater stability of end
expiratory volume.9
We have found that maternal smoking and
diminished airway function measured early in
life are independently associated with lower
levels of airway function at the end of the first
year. Although sGawEE was lower at 1 year of
age in infants with prior wheezing, our findings
suggest that this association may be mediated
by diminished premorbid airway function,
reflecting impaired growth and development
during fetal and very early life. Although a
family history of asthma was not independently
associated with impaired airway function at 1
year, this does not preclude an indirect eVect of
a genetic predisposition to asthma, possibly
mediated through its association with dimin-
ished premorbid airway function.2
The infants included in the current study
were representative of consecutive births in two
general practices in inner London.2 The preva-
lence of smoking by mothers during pregnancy
and postnatally is consistent with that reported
from national samples in the UK20 and was
biochemically validated. Physicians and par-
ents were blinded to respiratory function
results, as was the reviewer who ascertained
physician diagnosed episodes from medical
records, while those calculating respiratory
function parameters were blinded to the
wheezing and smoking exposure status of the
infants.
The first year cumulative incidence of physi-
cian diagnosed wheezing is comparable to that
reported previously from South London.21
Although higher than that reported from Tuc-
son,1 this may reflect the higher prevalence of
maternal smoking in this inner city population.
Cumulative incidence was higher in Perth, but
was estimated from parental report rather than
physician diagnosis of wheeze.3
Our findings are representative of the
spectrum of wheezing presenting in primary
care. In the current study almost half the
infants experiencing a first wheezing episode
sustained one or more subsequent episodes in
the first year. However, the majority of episodes
were managed in the community, with only
four infants requiring hospital admission. In
contrast, in the Tucson study all wheezing
illnesses were managed in the community, and
only one third (n=8) of infants experienced
further episodes.1 While there has been increas-
ing interest in the relation of early infections to
subsequent development of atopic illness,22 this
was not a prior hypothesis of this study. Thus,
prospective data on infections, including those
of the upper respiratory tract, are not available.
In this study the primary measure of airway
function was sGaw, a measure of airway
function corrected for lung size. While the ana-
tomical site of intrathoracic airway calibre can-
not be located precisely with any of the
currently available infant lung function tests,
plethysmographic measures of Raw and sGaw
are generally considered to reflect primarily the
calibre of the central airways,23 whereas maxi-
mal flow at FRC (V~max FRC), as used in sev-
eral previous epidemiological studies,1 14 24 is
thought to reflect more peripheral airway func-
tion. Although the latter is of value in detecting
early influences on airway function in infants,
resting lung volume, which was of specific
interest in this study, cannot be assessed simul-
taneously.
Diminution of airway calibre may reflect
several mechanisms including anatomical
changes in lumen size, increased thickness or
compliance of the airway wall, secretions,
bronchoconstriction, or relative lack of dis-
tending pressure due to low elastic recoil.25
However, since infants in the current study
were asymptomatic at testing with no evidence
of hyperinflation or any diVerence in sCrs, the
observed reduction in airway conductance at 1
year associated with maternal smoking or
diminished premorbid airway function most
likely reflects alterations in airway structure or
calibre. Our findings are consistent with altera-
tions in airway geometry in that diminished
airway function shortly after birth is thought to
reflect congenitally small airways and impaired
Table 5 End expiratory specific conductance (sGawEE) at 1 year: associations with prior wheezing and other factors
DiVerence in sGawEE
(/s/kPa) at 1 year 95% confidence interval p value
Univariate analyses:
Prior physician diagnosed wheeze (baseline: no wheeze) –0.45 –0.76 to –0.14 <0.01
Maternal smoking postnatally (baseline: no maternal smoking) –0.54 –0.81 to –0.27 <0.001
Family history of asthma (baseline: no family history) –0.31 –0.62 to 0.00 <0.05
sGawEE at 8 weeks of age (per unit (/s/kPa) reduction) –0.28 –0.13 to -0.43 <0.001
Sex (baseline: male) 0.006 –0.23 to 0.34 0.685
Multivariate analyses*:
Prior physician diagnosed wheeze (baseline: no wheeze) –0.21 –0.58 to 0.15 0.25
Maternal smoking postnatally (baseline: no maternal smoking) –0.40 –0.71 to –0.10 0.01
Family history of asthma (baseline: no family history) –0.04 –0.38 to 0.30 0.81
sGawEE at 8 weeks of age (per unit (/s/kPa) reduction) –0.20 –0.36 to -0.03 0.018
*Data calculated after allowing for those variables found to be significant in univariate analyses (prior wheeze, maternal smoking,
family history of asthma, and sGawEE at 8 weeks of age).
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fetal airway development.1 24 We did not find
any sex diVerences in sGaw in the current
study. In previous studies we have reported
marked sex diVerences in V~maxFRC when
using the “squeeze” technique,16 26 which
suggests that sex diVerences may relate prima-
rily to the size and function of the peripheral
rather than central airways and reflect sex
diVerences in respiratory development.27
While several population based longitudinal
studies have examined lung function during
early infancy in relation to subsequent respira-
tory symptoms and respiratory function in later
childhood, few have assessed the growth and
development of the respiratory system in later
infancy by including repeat measures of infant
lung function.3 28 Young et al observed reduced
forced expiratory flow at 1 year in infants with
parentally reported wheezing, but did not
report the association with prior respiratory
function.3 Tager et al observed diminished
forced expiratory flow at 18 months of age in
infants of mothers who smoked during preg-
nancy, but did not report the influence of prior
wheezing or a family history of asthma.28
While tPTEF:tE is diminished in young infants
who subsequently wheeze,1 2 our data do not
support the converse association of diminished
tPTEF:tE at 1 year in those with prior wheeze. We
have previously shown that tPTEF:tE is only
weakly related to measures of airway function
in young infants aged over 13 weeks.13 The
findings of the current study suggest that, in
older infants without clinically significant
airway disease, variation in the ratio of peak
tidal expiratory flow to expiratory time does
not reflect the mechanical properties of the
lung or airway calibre.
We found maternal smoking to be a
significant and independent predictor of di-
minished sGaw at 1 year, but cannot establish
the relevant timing of exposure since women
who smoked postnatally also smoked during
pregnancy. However, in this cohort Raw was
raised but sGaw was not diminished at 8 weeks
of age in infants whose mothers smoked in
pregnancy,2 suggesting that the eVects of
prenatal exposure to maternal smoking on lung
development may initially be mediated by
impaired fetal growth and micronutrient or
other maternal nutritional deficiencies.29 30
Our findings add to the growing body of evi-
dence supporting the association between
maternal smoking and impaired respiratory
function in oVspring.28 31 Elliot et al reported
that inner airway wall thickness was increased
in infants dying suddenly and unexpectedly at
about 6 months of age and whose mothers
smoked heavily during pregnancy and postna-
tally.32 They suggested that postnatal exposure
to tobacco smoke represents a true inhalational
insult to the airways, in contrast to in utero
exposure which may have indirect eVects on
the respiratory system mediated by alterations
in airway wall collagen thickness and neuro-
logical control of respiration. As most studies
are unable to distinguish the temporal eVects of
maternal smoking, direct evidence for these
hypotheses is lacking. However, the diVerent
patterns of airway abnormality observed at dif-
ferent ages in this and an earlier study16 suggest
that this is biologically plausible. Thus, in utero
exposure may be consistent with alterations in
control of respiration and airway growth and
development, and postnatal exposure with
diminished airway calibre due to airway wall
inflammation and oedema.
Information linking early measures of infant
respiratory function to spirometric and other
indices in later childhood and adult life are very
limited.33 In the Tucson Children’s Respiratory
Study, infants with transient early wheezing
were more likely to have persistence of earlier
impaired airway function to 6 years of age,
despite being currently asymptomatic.7 Chil-
dren with transient wheezing were also more
likely to have a mother who smoked and to
have non-reversible defects in forced expiratory
volume in 1 second (FEV1) by the age of 11.
34
In a subsequent report, reversible defects were
reported by the age of 13 in those with respira-
tory syncytial virus associated lower respiratory
illnesses in the first 3 years of life.35 Upton et al
reported diminished FEV1 in the adult oV-
spring of mothers who smoked36 and suggested
that maternal smoking may account for some
of the unexplained variance in airway function
in adult life. If this is the case, secular trends in
smoking by young women and mothers20
suggest that this may be a risk factor of
increasing public health importance. This is
particularly so in the light of recent work dem-
onstrating that diminished FEV1 is an impor-
tant predictor of all-cause mortality in adult
life.37 It is therefore increasingly relevant to
examine whether there are adverse eVects of
potentially avoidable factors such as maternal
smoking on the growth and development of the
respiratory system.
One important question has been to deter-
mine whether children who experience lower
respiratory illnesses in early life have pre-
existing abnormalities of airway function that
manifest during viral infections, or whether the
lower respiratory illness itself produces changes
in the lower airways that predispose the infant
to other problems. Our findings are consistent
with the hypothesis that, at a population level,
diminished premorbid airway function pro-
vides the link between wheezing lower respira-
tory illness and diminished airway function at 1
year. Maternal smoking remains an important
and avoidable cause of impaired airway devel-
opment and function in infancy.
We thank the parents and infants who took part; the general
practitioners and health visitors of the Chrisp Street and St
Stephen’s Road Health Centres for their support and permis-
sion to contact families under their care; Liane Pilgrim who
recruited and visited families, entered data and collated urine
specimens for cotinine analysis; Colin Feyerabend at the Poisons
Unit, New Cross Hospital for cotinine analyses; Debby
MacNally for help with retrieving medical records; and Helena
WagstaV for help with recruiting.
This research was supported by the Wellcome Trust, the
National Asthma Campaign, the British Lung Foundation, the
Dunhill Medical Trust, the Child Health Research Appeal
Trust, SIMS Portex Ltd, and the Muirhead Trust. Research at
the Institute of Child Health and Great Ormond Street Hospi-
tal for Children NHS Trust benefits from R&D funding
received from the NHS Executive.
Airway function at one year 685
www.thoraxjnl.com
 group.bmj.com on July 29, 2011 - Published by thorax.bmj.comDownloaded from 
1 Martinez FD, Morgan WJ, Wright AL, et al. Diminished
lung function as a predisposing factor for wheezing respira-
tory illness in infants. N Engl J Med 1988;319:1112–7.
2 Dezateux C, Stocks J, Dundas I, et al. Impaired airway func-
tion and wheezing in infancy. The influence of maternal
smoking and a genetic predisposition to asthma. Am J
Respir Crit Care Med 1999;159:403–10.
3 Young S, Arnott J, O’KeeVe PT, et al. The association
between early life lung function and wheezing during the
first 2 years of life. Eur Respir J 2000;15:151–7.
4 Dezateux C, Stocks J. Lung development and early origins
of childhood respiratory illness. Br Med Bull 1997;53:40–
57.
5 Rona RJ, Gulliford MC, Chinn S. EVects of prematurity
and intrauterine growth on respiratory health and lung
function in childhood. BMJ 1993;306:817–20.
6 Shaheen SO, Barker DJP. Early lung growth and chronic
airflow obstruction. Thorax 1994;49:533–6.
7 Martinez FD, Wright AL, Taussig LM, et al. Asthma and
wheezing in the first six years of life. N Engl J Med
1995;332:133–8.
8 Leeder SR, Corkhill RT, Wysocki MJ, et al. Influence of per-
sonal and family factors on ventilatory function of children.
Br J Prev Soc Med 1976;30:219–24.
9 Stocks J. Respiratory physiology during early life. Monaldi
Arch Chest Dis 1999;54:358–64.
10 Stocks J, Sly PD, Tepper RS, et al. Infant respiratory function
testing. New York: John Wiley, 1996.
11 Dundas I, Dezateux CA, Fletcher ME, et al. Comparison of
single-breath and plethysmographic measurements of
resistance in infancy. Am J Respir Crit Care Med 1995;151:
1451–8.
12 Stocks J, Dezateux CA, Jackson EA, et al. Analysis of tidal
breathing parameters in infancy: how variable is tPTEF:tE?
Am J Respir Crit Care Med 1994;150:1347–54.
13 Dezateux CA, Stocks J, Dundas I, et al. The relationship
between tPTEF:tE and specific airways conductance in
infancy. Pediatr Pulmonol 1994;18:299–307.
14 Young S, Le Souëf PN, Geelhoed GC, et al. The influence of
a family history of asthma and parental smoking on airway
responsiveness in early infancy. N Engl J Med 1991;324:
1168–73.
15 Stick SM, Burton PR, Gurrin L, et al. EVects of maternal
smoking during pregnancy and a family history of asthma
on respiratory function in newborn infants. Lancet
1996;348:1060–4.
16 Hoo A-F, Henschen M, Dezateux C, et al. Respiratory func-
tion among preterm infants whose mothers smoked during
pregnancy. Am J Respir Crit Care Med 1998;158:700–5.
17 Freeman JV, Cole TJ, Chinn S, et al. Cross sectional stature
and weight reference curves for the UK, 1990. Arch Dis
Child 1995;73:17–24.
18 Jarvis MJ, Tunstall-Pedoe H, Feyerabend C, et al. Compari-
son of tests used to distinguish smokers from nonsmokers.
Am J Public Health 1987;77:1435–8.
19 Cohen J. Statistical power analysis for the behavioural sciences.
Hillsdale, New Jersey: Erlbaum Associates, 1988.
20 Owen L, McNeill A, Callum C. Trends in smoking during
pregnancy in England, 1992–7: quota sampling surveys.
BMJ 1998;317:728.
21 Watkins CJ, Burton P, Leeder S, et al. Doctor diagnosis and
maternal recall of lower respiratory illness. Int J Epidemiol
1982;11:62–6.
22 Illi S, von Mutius E, Lau S, et al. Early childhood infectious
diseases and the development of asthma up to school age: a
birth cohort study. BMJ 2001;322:390–5.
23 Macklem PT. The physiology of small airways. Am J Respir
Crit Care Med 1998;157:S181–3.
24 Hanrahan JP, Tager IB, Segal MR, et al. The eVect of mater-
nal smoking during pregnancy on early infant lung
function. Am Rev Respir Dis 1992;145:1129–35.
25 Stocks J. Developmental physiology and methodology. Am J
Respir Crit Care Med 1995;151:S15–17.
26 Stocks J, Henschen M, Hoo A-F, et al. The influence of eth-
nicity and gender on airway function in preterm infants.
Am J Respir Crit Care Med 1997;156:1855–62.
27 Becklake MR, KauVmann F. Gender diVerences in airway
behaviour over the human life span. Thorax 1999;54:1119–
38.
28 Tager IB, Ngo L, Hanrahan JP. Maternal smoking during
pregnancy: eVects on lung function during the first 18
months of life. Am J Respir Crit Care Med 1995;152:977–
83.
29 Margetts BM, Jackson AA. Interactions between people’s
diet and their smoking habits: the dietary and nutritional
survey of British adults. BMJ 1993;307:1381–4.
30 Godfrey K, Robinson S, Barker DJP, et al. Maternal
nutrition in early and late pregnancy in relation to placen-
tal and fetal growth. BMJ 1996;312:410–4.
31 Stein RT, Holberg CJ, Sherrill D, et al. Influence of parental
smoking on respiratory symptoms during the first decade
of life. Am J Epidemiol 1999;149:1030–7.
32 Elliot J, Vullermin P, Robinson P. Maternal cigarette smok-
ing is associated with increased inner airway wall thickness
in children who die from sudden infant death syndrome.
Am J Respir Crit Care Med 1998;158:802–6.
33 Britton J, Martinez FD. The relationship of childhood respi-
ratory infection to growth and decline in lung function. Am
J Respir Crit Care Med 1996;154:S240–5.
34 Stern DA, Morgan WJ, Taussig LM, et al. Lung function at
age 11 in relation to early wheezing (abstract). Am J Respir
Crit Care Med 1999;159:148.
35 Stein RT, Sherrill D, Morgan WJ, et al. Respiratory syncytial
virus in early life and risk of wheeze and allergy by age 13
years. Lancet 1999;354:541–5.
36 Upton MN, Watt GCM, Davey-Smith G, et al. Permanent
eVects of maternal smoking on oVspring’s lung function.
Lancet 1998;352:453.
37 Hole DJ, Watt GCM, Davey-Smith G, et al. Impaired lung
function and mortality risk in men and women: findings
from the Renfrew and Paisley prospective population study.
BMJ 1996;313:711–5.
686 Dezateux, Stocks,Wade, et al
www.thoraxjnl.com
 group.bmj.com on July 29, 2011 - Published by thorax.bmj.comDownloaded from 
doi: 10.1136/thorax.56.9.680
 2001 56: 680-686Thorax
 
C Dezateux, J Stocks, A M Wade, et al.
 
maternal smoking
premorbid airway function, wheezing, and 
Airway function at one year: association with
 http://thorax.bmj.com/content/56/9/680.full.html
Updated information and services can be found at: 
These include:
References
 http://thorax.bmj.com/content/56/9/680.full.html#related-urls
Article cited in: 
 
 http://thorax.bmj.com/content/56/9/680.full.html#ref-list-1
This article cites 31 articles, 19 of which can be accessed free at:
service
Email alerting
box at the top right corner of the online article.
Receive free email alerts when new articles cite this article. Sign up in the
Collections
Topic
 (172 articles)Tobacco use (youth)   
 (1028 articles)Tobacco use   
 (6752 articles)Smoking   
 (14708 articles)Health education   
 (5275 articles)Asthma   
 (4040 articles)Airway biology   
 (27664 articles)Child health   
 (1448 articles)TB and other respiratory infections   
 
Articles on similar topics can be found in the following collections
Notes
 http://group.bmj.com/group/rights-licensing/permissions
To request permissions go to:
 http://journals.bmj.com/cgi/reprintform
To order reprints go to:
 http://group.bmj.com/subscribe/
To subscribe to BMJ go to:
 group.bmj.com on July 29, 2011 - Published by thorax.bmj.comDownloaded from 
